{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:15:24Z","timestamp":1790471724566,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jaci.2012.12.1578","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T12:26:34Z","timestamp":1363263994000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Higher mast cell load decreases the risk of Hymenoptera venom\u2013induced anaphylaxis in patients with mastocytosis"],"prefix":"10.1016","volume":"132","author":[{"given":"Bjorn","family":"van Anrooij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"van der Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.R.","family":"de Monchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicco","family":"van der Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C.","family":"van Voorst Vader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper J.","family":"van Doormaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne N.G.","family":"Oude Elberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2012.12.1578_bib1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1365-2222.2009.03324.x","article-title":"The natural history and epidemiology of insect venom allergy: clinical implications","volume":"39","author":"Bilo","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.12.1578_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(00)03647-3","article-title":"Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to hymenoptera stings","volume":"357","author":"Ludolph-Hauser","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2012.12.1578_bib3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with hymenoptera venom allergy: importance of baseline serum tryptase\u2014a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib4","first-page":"260","article-title":"Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children","volume":"21","author":"Cichocka-Jarosz","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.anai.2010.12.015","article-title":"Total tryptase levels indicate risk for systemic reactions to rush immunotherapy and mast cell activation","volume":"106","author":"Vegh","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1398-9995.2009.02302.x","article-title":"Basal serum tryptase as risk assessment for severe hymenoptera sting reactions in elderly","volume":"65","author":"Guenova","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.12.1578_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of side effects during the buildup phase of venom immunotherapy for hymenoptera venom allergy: the importance of baseline serum tryptase","volume":"126","author":"Rueff","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2222.2009.03436.x","article-title":"Serum concentration of baseline mast cell tryptase: Evidence for a decline during long-term immunotherapy for hymenoptera venom allergy","volume":"40","author":"Dugas-Breit","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.12.1578_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2222.2009.03251.x","article-title":"Elevated baseline serum tryptase, mastocytosis and anaphylaxis","volume":"39","author":"Muller","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.12.1578_bib11","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.12.1578_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1398-9995.2009.02118.x","article-title":"Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy","volume":"64","author":"Niedoszytko","year":"2009","journal-title":"Allergy"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.12.1578_bib14","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jaci.2007.05.001","article-title":"Risk assessment in anaphylaxis: current and future approaches","volume":"120","author":"Simons","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000329218","article-title":"Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience","volume":"157","author":"Wimazal","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib16","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"54","article-title":"Mastocytosis","author":"Horny","year":"2008"},{"key":"10.1016\/j.jaci.2012.12.1578_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaci.2012.12.1578_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014second national institute of allergy and infectious Disease\/Food allergy and anaphylaxis network symposium","volume":"47","author":"Sampson","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaci.2012.12.1578_bib19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-2133.1998.02514.x","article-title":"Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover","volume":"139","author":"Granerus","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0009-8981(81)90150-9","article-title":"Determination of N tau-methylhistamine in plasma and urine by isotope dilution mass fragmentography","volume":"113","author":"Keyzer","year":"1981","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jaci.2012.12.1578_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0009-8981(82)90247-9","article-title":"Determination of N tau-methylimidazoleacetic acid (a histamine metabolite) in urine by gas chromatography using nitrogen-phosphorus detection","volume":"121","author":"Keyzer","year":"1982","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jaci.2012.12.1578_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02142572","article-title":"Age dependent normal values of histamine and histamine metabolites in human urine","volume":"23","author":"Oosting","year":"1988","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaci.2012.12.1578_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00130832-200208000-00008","article-title":"Epidemiology of hymenoptera allergy","volume":"2","author":"Antonicelli","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.it.2009.12.007","article-title":"Exploring a regulatory role for mast cells: \u2018MCregs'?","volume":"31","author":"Frossi","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri2327","article-title":"Immunomodulatory mast cells: Negative, as well as positive, regulators of immunity","volume":"8","author":"Galli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1398-9995.2010.02521.x","article-title":"Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis","volume":"66","author":"Niedoszytko","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.12.1578_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-3083.2010.02427.x","article-title":"Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma","volume":"72","author":"Cabrera","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib28","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/eji.201141423","article-title":"The central role of CD30L\/CD30 interactions in allergic rhinitis pathogenesis in mice","volume":"41","author":"Fuchiwaki","year":"2011","journal-title":"Eur J\u00a0Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2567.2006.02354.x","article-title":"Deciphering CD30 ligand biology and its role in humoral immunity","volume":"118","author":"Kennedy","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2012.12.1578_bib30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20020319","article-title":"Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus","volume":"196","author":"Saraiva","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2012.12.1578_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jaci.2009.02.003","article-title":"Assessing anaphylactic risk? consider mast cell clonality","volume":"123","author":"Metcalfe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib32","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.12.1578_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.2012.01789.x","article-title":"Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis","volume":"89","author":"Kristensen","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaci.2012.12.1578_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2011.293","article-title":"An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis","volume":"26","author":"Teodosio","year":"2012","journal-title":"Leukemia"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:38:57Z","timestamp":1758789537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0091674913001838"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.12.1578","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher mast cell load decreases the risk of Hymenoptera venom\u2013induced anaphylaxis in patients with mastocytosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.12.1578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}